Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Companion Animals

Set Alert for Companion Animals

Aratana debates future of stem cell candidate following study

Aratana Therapeutics must decide if it will continue the development of a treatment candidate for canine osteoarthritis after analyzing the results of a recent study. 

Aratana Therapeutics Canine

Zomedica wraps up 2017 with several milestone achievements for pipeline

US animal health firm Zomedica Pharmaceuticals has achieved a number of milestones for its pet therapeutics pipeline in 2017. 

R&D Pharmaceuticals

European boost for Australian cannabis treatment firm

Australian animal health company CannPal has seen its European business prospects boosted with the granting of a small and medium size enterprise status (SME) by the European Medicines Agency (EMA). 

R&D Pain

Dechra makes a small but significant acquisition in New Zealand

Dechra Pharmaceuticals has again returned to Australasia for its latest acquisition. 

New Zealand Companion Animals

Jaguar taps the Middle East equine market with key deal in Dubai

Jaguar Health has opened up a range of commercial possibilities in the Middle East by securing a collaborative partnership with a notable Dubai-based firm.

Middle East and Africa United Arab Emirates

Le Vet bags decentralized approvals for dogs and cats in EU

Dutch firm Le Vet Pharma has received European approval for two generic companion animal products.

Europe Canine

Zoetis bivalent vaccine for canine influenza launched

US animal health company Zoetis has increased its canine influenza virus (CIV) vaccine portfolio with a new combination product.

North America United States

Pre-clinical study backs Panion's canine epilepsy treatment

A study of Swedish gene therapy firm Panion's epilepsy drug candidate has shown positive initial results. 

Europe Denmark

Leading EU expert on public health backs EPRUMA antibiotic initiatives

One of the European Parliament's leading advocates for improved public health in the EU has said understanding the effects of antibiotics in animal health is pivotal to making progress.

Europe European Commission

Oasmia to list veterinary assets on Nasdaq under AdvaVet

Swedish firm Oasmia Pharmaceuticals is aiming to list its veterinary assets on the Nasdaq through its wholly-owned US subsidiary. 

Companion Animals Operations

Bayer warns of growing parasite risks of global pet ownership

Bayer Animal Health said the growth of companion animals in developing countries has raised the increasing likelihood of pet owners being infected by their pets with zoonotic diseases. 

Bayer Animal Health Flea and tick

Dechra expands dermatology range with new feed product

UK firm Dechra Veterinary Products has launched a new complementary pet feed to help cats and dogs suffering with allergic skin conditions. 

Dechra Pharmaceuticals Feed & Additives
See All
Advertisement
UsernamePublicRestriction

Register